NASDAQ: MRSN       Mersana Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
17.57   -1.15 (6.14%)  17.25 - 19.394  545,724


Avg Volume (4 weeks):721,490
4 Weeks Range:16.55 - 19.89
4 Weeks Price Volatility (%):
52 Weeks Range:1.32 - 26.64
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company. It is focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. The company's most advanced platform, Dolaflexin, has been used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not currently amenable to treatment with traditional ADC-based therapies. Its lead product candidate, XMT-1522, is a HER2-targeted ADC is in a Phase 1 dose escalation study in primarily breast cancer patients as well as non-small cell lung cancer (NSCLC) and gastric cancer.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1579  4444  223  3154 

Top 10 Active Counters
 MGEN 1.26+0.74 
 TTNP 0.167+0.038 
 GE 7.42+0.32 
 LK 1.38+1.38 
 AAPL 111.20-5.40 
 SQQQ 24.65+2.59 
 NIO 27.51-0.93 
 NAKD 0.083-0.009 
 SNAP 42.86+1.32 
 BAC 23.47-0.38